Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Zalicus: Expanding Drug Pipeline Helps Make It a Strong Buy
Seeking Alpha
Wednesday, March 16, 2011 - 10:47am
tags:
Zalicus
Roche acquires PVT to strengthen diagnostics unit
Pharma Times, UK
Wednesday, March 16, 2011 - 10:46am
tags:
Roche, diagnostics, M&A, PVT
Human Genome: Buy the Pipeline Before Glaxo Does
Seeking Alpha
Wednesday, March 16, 2011 - 10:43am
tags:
GSK, Human Genome Sciences, lupus, Benlysta
A Big Pain for Pfizer: Embeda Is Recalled
Seeking Alpha
Wednesday, March 16, 2011 - 10:43am
tags:
Pfizer, King, painkillers, Embeda
Novartis maps out a blockbuster future for INC424
Fierce Biotech
Wednesday, March 16, 2011 - 9:21am
tags:
Novartis, INC424, Incyte, JAK inhibitors, ruxolitinib, myelofibrosis
Jazz’s Xyrem Hits The Right Notes
Forbes
Wednesday, March 16, 2011 - 9:19am
tags:
Jazz Pharmaceuticals, Xyrem, narcolepsy
Kendle Risk-Reward Remains Favorable
Seeking Alpha
Wednesday, March 16, 2011 - 9:18am
tags:
Kendle
Extending the Competition in Parkinson's Disease
Motley Fool
Wednesday, March 16, 2011 - 9:17am
tags:
Parkinson's Disease, Impax, Merck, Novartis, Pfizer, GSK
Astellas, Partners Reach Settlement With Teva on Tarceva Patent
Bloomberg
Wednesday, March 16, 2011 - 9:17am
tags:
Astellas, Teva Pharmaceuticals, Tarceva, patents
Pfizer: Bigger Not Necessarily Better
Seeking Alpha
Wednesday, March 16, 2011 - 9:16am
tags:
Pfizer
Progenics posts larger 4Q loss as revenue falls
Yahoo/AP
Wednesday, March 16, 2011 - 9:15am
tags:
earnings, Progenics Pharmaceuticals
Making sense of the Alzheimer's drug pipeline
Fierce Biotech Research
Tuesday, March 15, 2011 - 12:31pm
tags:
Alzheimer's disease, Razadyne, Nivalin, Ortho-McNeil-Janssen, Exelon, Novartis, Aricept, Eisai, Pfizer, Namenda, Merz, Forest Labs, Eli Lilly, Elan, JNJ, Roche, MorphoSys
Millennium expands cancer pact with red-hot Seattle Genetics
Fierce Biotech
Tuesday, March 15, 2011 - 12:27pm
tags:
Millennium, Seattle Genetics, antibody-drug conjugate
Sequenom Passes This Key Test
Motley Fool
Tuesday, March 15, 2011 - 12:26pm
tags:
Sequenom
Tougher Sentencing For Pharma Fraud?
Pharmalot
Tuesday, March 15, 2011 - 11:20am
tags:
fraud
Study: Statins may reduce prostate cancer risk
Fierce Pharma
Tuesday, March 15, 2011 - 11:09am
tags:
prostate cancer, statins
Novartis Has Largest Japan Exposure Among Big Pharma
Barron's
Tuesday, March 15, 2011 - 11:08am
tags:
Novartis, Japan, Pfizer, Merck, Eli Lilly, GSK, Bristol-Myers Squibb, AstraZeneca, Sanofi
Incyte cancer drug meets goal in Europe study
Yahoo/AP
Tuesday, March 15, 2011 - 10:03am
tags:
Incyte, Europe, ruxolitinib, Novartis
Daiichi Yet to Gain from Ranbaxy Buy
WSJ Online
Tuesday, March 15, 2011 - 9:07am
tags:
Daiichi Sankyo, Ranbaxy
The Consensus Opinion on Pfizer: Mostly Bullish
Motley Fool
Tuesday, March 15, 2011 - 9:06am
tags:
Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.